BusinessNew Patent on Software as a Therapeutic for Depression and other DisordersBy Nasdaq OMXApr 18, 2017, 12:02 PM UTC
BusinessNew Patent on Software as a Therapeutic for Depression and other DisordersBy Nasdaq OMXApr 18, 2017, 12:02 PM UTC
BusinessUSPTO Grants Composition of Matter Patent to Achillion for Small Molecule Complement Alternative Pathway Factor D InhibitorsBy Nasdaq OMXMar 21, 2017, 8:05 PM UTC
BusinessCell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other DiseasesBy Nasdaq OMXMar 15, 2017, 12:01 PM UTC
BusinessCell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other DiseasesBy Nasdaq OMXMar 15, 2017, 12:01 PM UTC
BusinessNetWorth Services Announces Patent on Cost Basis ApplicationBy Nasdaq OMXMar 9, 2017, 8:58 PM UTC
BusinessAXIM Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome With CanChew Plus® Cannabidiol (CBD) Chewing GumBy Nasdaq OMXMar 7, 2017, 2:02 PM UTC
BusinessAXIM Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome With CanChew Plus® Cannabidiol (CBD) Chewing GumBy Nasdaq OMXMar 7, 2017, 2:02 PM UTC
